Ten distinguished members of the American Society for Radiation Oncology (ASTRO) have been named ASTRO Fellows, in the 10th anniversary year that the designation has been awarded. The 2016 class of Fellows will be recognized at an awards ceremony during ASTRO’s 58th Annual Meeting, to be held September 25-28, 2016, in Boston.
The ASTRO Fellows designation, or FASTRO, honors individuals who have significantly added to the field of radiation oncology in the areas of research, education, patient care or service and leadership. Designees also have been an active or emeritus member of ASTRO for at least 15 years, giving the equivalent of 10 years of service to ASTRO through committee service and similar activities. With the addition of the 2016 class, a total of 269 ASTRO members have received the FASTRO designation since the inception of the award in 2006.
“The individuals in this class of ASTRO Fellows demonstrate both talent and commitment across multiple aspects of radiation oncology, particularly in clinical care, research, service and education,” said ASTRO Chair Bruce D. Minsky, MD, FASTRO. “As is the case for our other Fellows, the clinicians and researchers in the 2016 cohort show a clear dedication to improving patients’ lives and advancing our field, especially through service to ASTRO and its initiatives.”
The new ASTRO Fellows include:
- H. Joseph Barthold, MD, Beth Israel Deaconess Hospital-Plymouth, Plymouth, Massachusetts
- Jennifer R. Bellon, MD, Dana-Farber Cancer Institute, Harvard Medical School, Boston
- Laura A. Dawson, MD, Princess Margaret Cancer Centre, University of Toronto, Toronto
- Theodore L. DeWeese, MD, Johns Hopkins University, Baltimore
- Shalom Kalnicki, MD, Montefiore Medical Center, Albert Einstein College of Medicine, New York
- Nancy P. Mendenhall, MD, University of Florida, Gainesville, Florida
- William M. Mendenhall, MD, University of Florida, Gainesville, Florida
- Todd Pawlicki, PhD, University of California San Diego, La Jolla, California
- Timothy D. Solberg, PhD, University of California San Francisco, San Francisco
- John H. Suh, MD, Cleveland Clinic, Cleveland
ASTRO’s 58th Annual Meeting, the nation’s premier scientific meeting in radiation oncology, will be held September 25-28, 2016, at the Boston Convention and Exhibition Center in Boston, Massachusetts. The 2016 Annual Meeting is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team. Led by ASTRO President David C. Beyer, MD, FASTRO, the 2016 meeting will feature keynote addresses from Kathleen Sebelius, former U.S. Secretary of Health and Human Services; Thomas James Lynch Jr., MD, Chair and CEO, Massachusetts General Physicians Organization; and Jason Ragogna, general manager, SMS and Safety Alliances, Corporate Safety, Security, and Compliance, Delta Air Lines, Inc. The Presidential Symposium, “Prostate Cancer: Defining Value and Delivering It,” highlights the meeting’s theme of “Enhancing Value, Improving Outcomes” and will feature recent practice-changing studies and current developments in value-based care for prostate cancer. ASTRO’s four-day scientific meeting will feature a record number of abstracts, including 368 oral presentations, 1,760 posters and 180 digital posters in more than 50 educational sessions and 20 scientific panels for 20 disease-site tracks. For more information about ASTRO’s 58th Annual Meeting, visit www.astro.org/AnnualMeeting.